Zerhouni for a day?

Ever find yourself thinking, 'boy, if I ran the NIH, things would be different?' Well, two bloggers named Geoff Davis and Peter Fiske want to give you that chance -- virtually. Yesterday, at the linkurl:North Carolina Science Blogging Conference;http://wiki.blogtogether.org/blogtogether/ , Davis announced 'Zerhouni for a Day,' a linkurl:feature;http://blog.phds.org/2007/1/19/challenge on their blog soliciting comments on what you would do if you were charge of the NIH and NSF. The trends in NIH

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Ever find yourself thinking, 'boy, if I ran the NIH, things would be different?' Well, two bloggers named Geoff Davis and Peter Fiske want to give you that chance -- virtually. Yesterday, at the linkurl:North Carolina Science Blogging Conference;http://wiki.blogtogether.org/blogtogether/ , Davis announced 'Zerhouni for a Day,' a linkurl:feature;http://blog.phds.org/2007/1/19/challenge on their blog soliciting comments on what you would do if you were charge of the NIH and NSF. The trends in NIH funding will be no surprise to readers of The Scientist. Neither, however, will the fact that despite the complaints about funding levels, the number of PhDs and postdocs has risen. That means that the flattening of the NIH budget isn't the only thing responsible for declining grant approval rates, as we linkurl:reported in September;http://www.the-scientist.com/2006/9/1/42/1/ . The conference was, to my knowledge, the first time so many science bloggers had been in a room together. There were about 170 people there, from middle school teachers to tenured professors of biology. Check out the linkurl:program;http://wiki.blogtogether.org/blogtogether/show/Conference+Program for more, and find out what people are saying about the conference linkurl:here;http://wiki.blogtogether.org/blogtogether/show/Conference+Links+and+Liveblogging .
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies